(LRGG) Macquarie Trust - Overview
Etf: Large-Cap, Growth, Stocks, Equity, Non-Diversified
Dividends
| Dividend Yield | 0.16% |
| Yield on Cost 5y | 0.18% |
| Yield CAGR 5y | 27.78% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.3% |
| Relative Tail Risk | 6.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -16.38 |
| Character TTM | |
|---|---|
| Beta | 0.875 |
| Beta Downside | 0.857 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.69% |
| CAGR/Max DD | 0.26 |
Description: LRGG Macquarie Trust January 01, 2026
The Macquarie Large Growth ETF (NYSE ARCA: LRGG) seeks to allocate at least 80% of its net assets-plus any investment-grade borrowings-into large-cap equities that the manager, Delaware Management Company, deems high-quality, growth-oriented businesses with durable competitive advantages. Because the fund is classified as non-diversified, its holdings are concentrated in a relatively small number of stocks that the adviser expects to deliver long-term earnings expansion.
Key metrics (as of the latest filing) include an expense ratio of 0.45%, assets under management of roughly $550 million, and a top-10 holding concentration of about 40%, dominated by sectors such as technology (≈30% of assets), consumer discretionary (≈20%), and health care (≈15%). The ETF’s performance is closely tied to macro drivers like U.S. GDP growth, corporate earnings trends, and the Federal Reserve’s monetary policy stance, which influence growth-stock valuations.
For a deeper quantitative dive, you might explore ValueRay’s analytics platform to see how LRGG’s risk-adjusted returns compare with peer large-growth ETFs.
What is the price of LRGG shares?
Over the past week, the price has changed by -4.66%, over one month by -8.41%, over three months by -8.45% and over the past year by -2.43%.
Is LRGG a buy, sell or hold?
What are the forecasts/targets for the LRGG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 27.4 | 0.8% |
LRGG Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 357.9m USD (357.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 357.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 357.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.14% (E(357.9m)/V(357.9m) * Re(9.14%) + (debt-free company))
Discount Rate = 9.14% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)